Lot 1

Consorci Hospital Clínic de Barcelona (HCB)

Published: Jul 5, 2026

Updated: Jul 6, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Spain, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before August 5, 2026.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, originating from Spain and sourced via ted, is for 'Lot 1: Fludesoxiglucosa 18F - máxima concentración.' This indicates a procurement for a specific radiopharmaceutical product, likely for medical imaging applications such as Positron Emission Tomography (PET) scans. The contracting authority, presumably a healthcare institution in Spain, is seeking a supplier capable of providing Fludesoxiglucosa (18F) at the highest possible concentration. Typical requirements for the supply of radiopharmaceuticals include strict adherence to Good Manufacturing Practices (GMP), robust quality control measures, and reliable, timely delivery to clinical sites. Suppliers must demonstrate the ability to maintain the integrity and specified concentration of the radioactive tracer throughout the supply chain. This often involves specialized logistics, including temperature-controlled transport and secure handling procedures. Bidders will need to provide detailed product specifications, certificates of analysis, and evidence of regulatory compliance within Spain and the EU. The tender aims to secure a consistent and high-quality supply of this critical diagnostic agent for patient care and medical research in Spain.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on July 5, 2026. Last refreshed today. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Consorci Hospital Clínic de Barcelona (HCB)

Consorci Hospital Clínic de Barcelona (HCB) has issued 60 procurement notices on BidsFactory, including 4 currently open and 45 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Information & Communication Technology. All notices are published for Spain. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: July 5, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is August 5, 2026. You have 31 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Consorci Hospital Clínic de Barcelona (HCB) in Spain. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Spain. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.